Feedback / Questions
PVX108 - Aravax
https://www.prnewswire.com/news-releases/aravax-pty-ltd-announces-opening-of-ind-for-phase-2-clinical-trials-of-pvx108-a-next-generation-immunotherapy-for-the-treatment-of-peanut-allergy-301495585.html
Mar 4, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next